344 results on '"Niino, M."'
Search Results
2. DOCK10 mutant L1903Y complexed with Rac1
3. Crystal structure of the DHR-2 domain of DOCK10 in complex with Cdc42 (T17N mutant)
4. Crystal structure of the DHR-2 domain of DOCK10 in complex with Rac1
5. Crystal structure of human acetylcholinesterase in complex with tacrine
6. Consistent increase in the prevalence and female ratio of multiple sclerosis over 15 years in northern Japan
7. Crystal structure of human acetylcholinesterase
8. Structure of human acetylcholinesterase in complex with tacrine
9. Crystal structure of human acetylcholinesterase in complex with donepezil
10. Cryo-EM structure of the human ELMO1-DOCK5-Rac1 complex
11. Structural basis for the altered drug sensitivities of non-small cell lung cancer-associated mutants of human epidermal growth factor receptor
12. Design of a Concentration Solar Thermoelectric Generator
13. Crystal structure of the DOCK8 DHR-1 domain
14. Structure of the DOCK8 DHR-1 domain crystallized with di-C8-phosphatidylinositol-(4,5)-bisphosphate
15. Seroconversion of neuromyelitis optica spectrum disorder with hyperCKemia: a case report
16. Impact of screening with thyroid ultrasonography in myasthenia gravis patients
17. Solution structure of ELMO1 RBD
18. Effect of High Fat Diet on NKT Cell Function and NKT Cell-mediated Regulation of Th1 Responses
19. Nonhemorrhagic venous infarction of the spinal cord without spinal vascular malformation
20. Heat shock protein 70 gene polymorphism in Japanese patients with multiple sclerosis
21. DOCK7 mutant I1836Y complexed with Cdc42
22. Crystal structure of the DHR-2 domain of DOCK7 in complex with Cdc42
23. Prostaglandin E 1 protects cultured spinal neurons against the effects of nitric oxide toxicity
24. Baló's concentric sclerosislike lesion in the brainstem of a multiple sclerosis patient
25. Effect of plasma activated sintering (PAS) parameters on densification of copper powder
26. A local selection criterion for the composition of graded thermoelectric generators
27. Crystal structure of HCK kinase complexed with a pyrrolo-pyrimidine inhibitor 7-[trans-4-(4-methylpiperazin-1-yl)cyclohexyl]-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
28. Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor (S)-2-(((1r,4S)-4-(4-amino-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)cyclohexyl)amino)-4-methylpentanoic acid
29. Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor (S)-2-(((1r,4S)-4-(4-amino-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)cyclohexyl)amino)-N,N,4-trimethylpentanamide
30. Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor (S)-2-(((1r,4S)-4-(4-amino-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)cyclohexyl)amino)-N,4-dimethylpentanamide
31. Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor (S)-2-(((1r,4S)-4-(4-amino-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)cyclohexyl)amino)-4-methylpentanamide
32. Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor (S)-ethyl2-(((1r,4S)-4-(4-amino-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)cyclohexyl)amino)-4-methylpentanoate
33. Crystal structure of the membrane-distal domain of mouse lysosome-associated membrane protein 2 (LAMP-2)
34. Crystal structure of the membrane-proximal domain of mouse lysosome-associated membrane protein 1 (LAMP-1)
35. Crystal structure of the kinase domain of TRAF2 and NCK-interacting protein kinase with NCB-0846
36. Crystal structure of the kinase domain of human TRAF2 and NCK-interacting protein kinase in complex with compund 9
37. Crystal structure of the kinase domain of human TRAF2 and NCK-interacting protein kinase
38. Bubble mode of flow of a gas-liquid mixture in a vertical pipe
39. Oxidized E.coli Lon Proteolytic domain
40. Oxidized-form structure of E.coli Lon Proteolytic domain
41. Reduced-form structure of E.coli Lon Proteolytic domain
42. Reduced E.coli Lon Proteolytic domain
43. Evaluation of NEDA and clinical characteristics in multiple sclerosis patients with high serum sema4a levels
44. Assured diagnostic critera of myasthenia gravis by the task force for evidence-based diagnostic and therapeutic algorithms for the national policy of intractable diseases of Japan
45. Safety of delayed-release dimetyl fumarate in Japanese patients with relapsing multiple sclerosis: Subgroup analysis of the apex Part 1 study
46. B cell-activating factor of the TNF family expands circulating transitional B cells in multiple sclerosis patients treated with fingolimod
47. Clinical and genetic features of Japanese patients with multiple sclerosis and neuromyelitis optica spectrum disorder based on Japan multiple sclerosis biobank
48. Useful scales for recognition of severe disease status in patients with multiple sclerosis in Japan
49. Crystal structure of HLA-DP5 in complex with Cry j 1-derived peptide (residues 214-222)
50. Crystal structure of human Interleukin-5 in complex with its alpha receptor
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.